Clover Health Investments (NASDAQ:CLOV) VP Sells 3,170 Shares of Stock

Clover Health Investments, Corp. (NASDAQ:CLOV) VP Joseph Frank Oldakowski sold 3,170 shares of Clover Health Investments stock in a transaction on Wednesday, September 16th. The shares were sold at an average price of $4.64, for a total transaction of $14,708.80. Following the completion of the transaction, the vice president owned 275,897 shares in the company, valued at approximately $1,280,162.08. This trade represents a 1.14% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Joseph Frank Oldakowski also recently made the following trade(s):

• On Monday, September 14th, Joseph Frank Oldakowski sold 20,000 shares of Clover Health Investments stock. The stock was sold at an average price of $5.16, for a total transaction of $103,200.00.

Clover Health Investments Price Performance

Shares of CLOV stock traded down $0.02 during mid-day trading on Thursday, hitting $4.54. The stock had a trading volume of 3,689,705 shares, compared to its average volume of 6,127,158. The firm has a market cap of $2.41 billion, a PE ratio of -90.78 and a beta of 2.47. The company’s 50-day simple moving average is $4.42 and its 200-day simple moving average is $3.60. Clover Health Investments, Corp. has a fifty-two week low of $1.58 and a fifty-two week high of $5.59.

Clover Health Investments (NASDAQ:CLOV) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $0.05 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.04 by $0.01. The business had revenue of $743.17 million for the quarter, compared to analyst estimates of $728.27 million. Clover Health Investments had a negative net margin of 0.74% and a negative return on equity of 4.20%. On average, analysts expect that Clover Health Investments, Corp. will post 0.06 EPS for the current year.

Analyst Upgrades and Downgrades

Several research firms have recently commented on CLOV. Zacks Research raised Clover Health Investments to a “hold” rating in a report on Monday. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Clover Health Investments in a report on Wednesday, June 24th. Canaccord Genuity Group increased their price objective on Clover Health Investments from $4.20 to $5.50 and gave the stock a “buy” rating in a research report on Tuesday, July 21st. UBS Group raised their target price on Clover Health Investments from $4.75 to $5.00 and gave the company a “neutral” rating in a report on Thursday, August 6th. Finally, Wall Street Zen lowered shares of Clover Health Investments from a “strong-buy” rating to a “buy” rating in a research report on Sunday, August 16th. Two equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $4.75.

Institutional Trading of Clover Health Investments

Several large investors have recently modified their holdings of CLOV. RFG Advisory LLC purchased a new stake in Clover Health Investments in the 1st quarter valued at approximately $35,000. Ketron Financial purchased a new stake in shares of Clover Health Investments in the fourth quarter valued at $39,000. Public Employees Retirement System of Ohio acquired a new stake in shares of Clover Health Investments during the 2nd quarter worth about $42,000. Kestra Private Wealth Services LLC boosted its position in Clover Health Investments by 44.1% during the first quarter. Kestra Private Wealth Services LLC now owns 24,525 shares of the company’s stock worth $43,000 after acquiring an additional 7,500 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd acquired a new stake in shares of Clover Health Investments during the first quarter worth $45,000. 19.77% of the stock is currently owned by institutional investors and hedge funds.

Clover Health Investments Company Profile

Clover Health Investments, Inc is a healthcare technology and insurance company focused on providing Medicare Advantage plans to eligible Medicare beneficiaries. Its insurance business offers medical coverage and related healthcare benefits through plans available in select counties across the United States.

The company also develops and uses Clover Assistant, a technology platform designed to support physicians with patient information, clinical insights, care recommendations and tools intended to help improve healthcare outcomes.